Walgreens EBITDA 2010-2024 | WBA
Walgreens annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Walgreens EBITDA for the quarter ending August 31, 2024 was $-0.307B, a 238.29% decline year-over-year.
- Walgreens EBITDA for the twelve months ending August 31, 2024 was $-11.405B, a 160.86% increase year-over-year.
- Walgreens 2024 annual EBITDA was $-11.405B, a 160.86% increase from 2023.
- Walgreens 2023 annual EBITDA was $-4.372B, a 215.14% decline from 2022.
- Walgreens 2022 annual EBITDA was $3.797B, a 19.55% increase from 2021.
Walgreens Annual EBITDA
(Millions of US $) |
| 2024 |
$-11,405 |
| 2023 |
$-4,372 |
| 2022 |
$3,797 |
| 2021 |
$3,176 |
| 2020 |
$3,250 |
| 2019 |
$6,968 |
| 2018 |
$8,250 |
| 2017 |
$7,273 |
| 2016 |
$7,756 |
| 2015 |
$6,725 |
| 2014 |
$6,127 |
| 2013 |
$5,871 |
| 2012 |
$4,630 |
| 2011 |
$5,451 |
| 2010 |
$4,488 |
| 2009 |
$4,222 |
Walgreens Quarterly EBITDA
(Millions of US $) |
| 2024-08-31 |
$-307 |
| 2024-05-31 |
$761 |
| 2024-02-29 |
$-12,478 |
| 2023-11-30 |
$619 |
| 2023-08-31 |
$222 |
| 2023-05-31 |
$179 |
| 2023-02-28 |
$831 |
| 2022-11-30 |
$-5,604 |
| 2022-08-31 |
$-246 |
| 2022-05-31 |
$285 |
| 2022-02-28 |
$1,874 |
| 2021-11-30 |
$1,884 |
| 2021-08-31 |
$1,486 |
| 2021-05-31 |
$1,738 |
| 2021-02-28 |
$1,385 |
| 2020-11-30 |
$-1,433 |
| 2020-08-31 |
$1,052 |
| 2020-05-31 |
$-962 |
| 2020-02-29 |
$1,657 |
| 2019-11-30 |
$1,503 |
| 2019-08-31 |
$1,230 |
| 2019-05-31 |
$1,708 |
| 2019-02-28 |
$2,101 |
| 2018-11-30 |
$1,929 |
| 2018-08-31 |
$1,915 |
| 2018-05-31 |
$2,091 |
| 2018-02-28 |
$2,621 |
| 2017-11-30 |
$1,623 |
| 2017-08-31 |
$1,443 |
| 2017-05-31 |
$2,014 |
| 2017-02-28 |
$1,933 |
| 2016-11-30 |
$1,883 |
| 2016-08-31 |
$1,621 |
| 2016-05-31 |
$1,983 |
| 2016-02-29 |
$2,302 |
| 2015-11-30 |
$1,850 |
| 2015-08-31 |
$1,314 |
| 2015-05-31 |
$1,839 |
| 2015-02-28 |
$1,985 |
| 2014-11-30 |
$1,587 |
| 2014-08-31 |
$1,539 |
| 2014-05-31 |
$1,497 |
| 2014-02-28 |
$1,684 |
| 2013-11-30 |
$1,407 |
| 2013-08-31 |
$1,782 |
| 2013-05-31 |
$1,440 |
| 2013-02-28 |
$1,627 |
| 2012-11-30 |
$1,022 |
| 2012-08-31 |
$896 |
| 2012-05-31 |
$1,169 |
| 2012-02-29 |
$1,388 |
| 2011-11-30 |
$1,177 |
| 2011-08-31 |
$1,554 |
| 2011-05-31 |
$1,220 |
| 2011-02-28 |
$1,463 |
| 2010-11-30 |
$1,214 |
| 2010-08-31 |
$1,008 |
| 2010-05-31 |
$1,092 |
| 2010-02-28 |
$1,334 |
| 2009-11-30 |
$1,054 |
| 2009-08-31 |
$936 |
| 2009-05-31 |
$1,110 |
| 2009-02-28 |
$1,271 |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$8.074B |
$147.658B |
|
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.
|
